MAPK1/ERK2 has been implicated in myriad cancers through involvement in key pathways and via miRNA regulation [31, 32, 33], and has been implicated as an oncogene during NSCLC progression and significantly promoted the proliferation, migration, and invasion of NSCLC cell lines in vitro [34]. This evidence concerns the gene MAPK1 and cancer.